|
|
|
Insider
Information: |
Ajer Jeffrey Robert |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
100,920 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,960,934 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
100,920 |
|
|
Total
Value |
$5,960,934 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-80.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-03-22 |
4 |
AS |
$81.00 |
$167,913 |
D/D |
(2,073) |
65,385 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-04-02 |
4 |
AS |
$80.12 |
$169,774 |
D/D |
(2,119) |
52,914 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-10-14 |
4 |
AS |
$79.91 |
$169,489 |
D/D |
(2,121) |
61,281 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2019-09-20 |
4 |
AS |
$20.24 |
$45,540 |
D/D |
(2,250) |
18,250 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2020-09-21 |
4 |
AS |
$19.74 |
$44,415 |
D/D |
(2,250) |
20,125 |
0 |
% |
|
NKTR |
Nektar Therapeutics |
Director |
|
2019-09-30 |
4 |
AS |
$18.06 |
$42,893 |
D/D |
(2,375) |
22,375 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Officer |
|
2016-03-03 |
4 |
D |
$89.57 |
$214,520 |
D/D |
(2,395) |
48,137 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-04-08 |
4 |
AS |
$79.98 |
$192,512 |
D/D |
(2,407) |
63,064 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-10-26 |
4 |
AS |
$73.60 |
$201,590 |
D/D |
(2,739) |
55,853 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-09 |
4 |
AS |
$82.39 |
$244,863 |
D/D |
(2,972) |
55,332 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-01-22 |
4 |
OE |
$21.51 |
$64,530 |
D/D |
3,000 |
13,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-01-22 |
4 |
AS |
$55.00 |
$165,000 |
D/D |
(3,000) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-07-20 |
4 |
OE |
$63.10 |
$189,300 |
D/D |
3,000 |
38,605 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-07-20 |
4 |
AS |
$150.00 |
$450,000 |
D/D |
(3,000) |
35,605 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-08-11 |
4 |
AS |
$95.62 |
$286,860 |
D/D |
(3,000) |
44,088 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-11-02 |
4 |
AS |
$86.12 |
$258,360 |
D/D |
(3,000) |
41,088 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2020-09-28 |
4 |
AS |
$17.25 |
$56,063 |
D/D |
(3,250) |
25,975 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-15 |
4 |
D |
$92.50 |
$304,140 |
D/D |
(3,288) |
43,222 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-09-22 |
4 |
OE |
$37.46 |
$131,897 |
D/D |
3,521 |
50,110 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-09-22 |
4 |
AS |
$95.00 |
$334,495 |
D/D |
(3,521) |
47,944 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-22 |
4 |
D |
$81.36 |
$291,513 |
D/D |
(3,583) |
56,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-22 |
4/A |
D |
$81.36 |
$292,733 |
D/D |
(3,598) |
56,555 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2019-03-22 |
4 |
D |
$88.05 |
$316,804 |
D/D |
(3,598) |
51,131 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-03-20 |
4 |
D |
$73.05 |
$262,907 |
D/D |
(3,599) |
70,667 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-15 |
4 |
D |
$83.57 |
$305,114 |
D/D |
(3,651) |
51,681 |
0 |
- |
|
174 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|